Evidence map›Paper›PMID 41079831›Full record

ArticleClinical case reports2025

Neuroleptic Malignant Syndrome: A Case Report of the Oldest Man in Literature.

Forouzan Elyasi, Mohsen Aarabi, Majidreza Adelani, Arghavan Fariborzifar, Marzieh Azizi

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Forouzan ElyasiSexual and Reproductive Health Research Center, Psychiatry and Behavioral Sciences Research Center, Addiction Institute Mazandaran University of Medical Sciences Sari Iran.ORCID https://orcid.org/0000-0002-6872-481X
Mohsen AarabiDepartment of Family Medicine, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran.
Majidreza AdelaniDepartment of Internal Medicine, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran.
Arghavan FariborzifarDepartment of Psychiatry, Mental Health Research Center, Psychosocial Health Research Institute (PHRI), School of Medicine Iran University of Medical Sciences Tehran Iran.
Marzieh AziziSexual and Reproductive Health Research Center, Faculty of Nursing and Midwifery Mazandaran University of Medical Sciences Sari Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A diagnosis of neuroleptic malignant syndrome (NMS) was made in a 96-year-old man, representing the oldest documented case in the existing medical literature. Even at very low doses of antipsychotic medications, older adults are more likely to develop NMS. This increased susceptibility may exacerbate other risk factors, such as preexisting neurological disorders or the concurrent use of cholinesterase inhibitors.

Indexed as

adverse drug reactionAlzheimer's diseaseelderlyhaloperidolneuroleptic malignant syndrome

Identifiers

PMID41079831
PMCPMC12513817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.